US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Therapeutics

33.58

-0.1500-0.44%

Post-market: 33.580.00000.00%16:04 EDT

Volume:120.66K

Turnover:4.10M

Market Cap:945.15M

PE:-18.98

High:34.90

Open:33.71

Low:33.51

Close:33.73

Loading ...

Overview Company News Filings

Prescient Therapeutics Announces Cessation of Securities

Top Executives Make Significant Moves with Bicycle Therapeutics Stock!

Cathie Wood’s ARK Investment buys 659K shares of Beam Therapeutics today

Century Therapeutics Stock Rises on Job Cuts

Century Therapeutics Announces Major Workforce Reduction

Denali Therapeutics’ Promising Developments and FDA Milestones Support Buy Rating

William Blair Sticks to Their Buy Rating for LENZ Therapeutics (LENZ)

Sector Update: Health Care Stocks Lean Lower Premarket Monday

MT Newswires Live

Denali Therapeutics’ FDA Priority Review for New Therapy

Alterity Therapeutics Announces Change in Substantial Holding

Lenz Therapeutics, Laboratoires Thea enter license, commercialization agreement

LENZ Therapeutics and Théa Ink $70M Deal for LNZ100 Eye Drop Commercialization in Canada

Lenz Therapeutics Inc - Eligible for Over $70 Mln in Payments and Royalties

THOMSON REUTERS

Lenz Therapeutics and Laboratoires THÉa Announce Exclusive License and Commercialization Agreement for Lnz100 in Canada

THOMSON REUTERS

Denali Therapeutics Announces FDA Acceptance and Priority Review of Biologics License Application (BLA) for Tividenofusp Alfa for Hunter Syndrome (MPS II)

Allarity Therapeutics Announces Appointment of Jeff Ervin as Chief Financial Officer

LENZ Therapeutics and Laboratoires Théa Announce Exclusive License and Commercialization Agreement for LNZ100 in Canada

Unicycive Therapeutics to Present at the H.C. Wainwright 4th Annual Kidney Virtual Conference

Truist Lowers Price Target on Edgewise Therapeutics to $46 From $50, Keeps Buy Rating

MT Newswires Live

HighTide Therapeutics Completes Successful Share Placement

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/LENZ/news?page=10"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LENZ","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LENZ\",,,,,undefined,":{"symbol":"LENZ","market":"US","secType":"STK","nameCN":"Therapeutics","latestPrice":33.58,"timestamp":1753128000000,"preClose":33.73,"halted":0,"volume":120659,"hourTrading":{"tag":"盘后","latestPrice":33.58,"preClose":33.58,"latestTime":"16:04 EDT","volume":3551,"amount":119242.57999999999,"timestamp":1753128251120},"delay":0,"floatShares":12729900,"shares":28146154,"eps":-1.769251,"marketStatus":"Post-Mkt","change":-0.15,"latestTime":"07-21 16:46:04 EDT","open":33.71,"high":34.8988,"low":33.505,"amount":4100201.245014,"amplitude":0.041322,"askPrice":35,"askSize":100,"bidPrice":32.5,"bidSize":15,"shortable":3,"etf":0,"ttmEps":-1.769251,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1753142400000},"marketStatusCode":4,"adr":0,"listingDate":1624593600000,"exchange":"NASDAQ","adjPreClose":33.73,"postHourTrading":{"tag":"盘后","latestPrice":33.58,"preClose":33.58,"latestTime":"16:04 EDT","volume":3551,"amount":119242.57999999999,"timestamp":1753128251120},"volumeRatio":0.380359,"impliedVol":0.9395,"impliedVolPercentile":0.8571},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LENZ\",,,,,undefined,":{"symbol":"LENZ","floatShares":12729900,"roa":"-17.75%","roe":"-24.47%","lyrEps":-2.338654,"volumeRatio":0.380359,"shares":28146154,"dividePrice":0,"high":34.8988,"amplitude":0.041322,"preClose":33.73,"low":33.505,"week52Low":16.535,"pbRate":"4.92","week52High":38.93,"institutionHeld":0,"latestPrice":33.58,"committee":-0.73913,"eps":-1.769251,"divideRate":0,"volume":120659,"delay":0,"ttmEps":-1.769251,"open":33.71,"prevYearClose":28.87,"prevWeekClose":33.73,"prevMonthClose":29.31,"prevQuarterClose":29.31,"fiveDayClose":33.73,"twentyDayClose":29.94,"sixtyDayClose":26.95},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LENZ\",pageSize:20,pageCount:10,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2549789593","title":"Prescient Therapeutics Announces Cessation of Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2549789593","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549789593?lang=en_us&edition=fundamental","pubTime":"2025-07-08 10:47","pubTimestamp":1751942831,"startTime":"0","endTime":"0","summary":"An update from Prescient Therapeutics Limited ( ($AU:PTX) ) is now available. Prescient Therapeutics Limited announced the cessation of 1,950,000 s...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/prescient-therapeutics-announces-cessation-of-securities?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/prescient-therapeutics-announces-cessation-of-securities?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","LENZ","BK4007","BK4139"],"gpt_icon":0},{"id":"2549988415","title":"Top Executives Make Significant Moves with Bicycle Therapeutics Stock!","url":"https://stock-news.laohu8.com/highlight/detail?id=2549988415","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549988415?lang=en_us&edition=fundamental","pubTime":"2025-07-08 10:01","pubTimestamp":1751940105,"startTime":"0","endTime":"0","summary":"New insider activity at Bicycle Therapeutics ( ($BCYC) ) has taken place on July 7, 2025. In recent transactions involving Bicycle Therapeutics sto...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/top-executives-make-significant-moves-with-bicycle-therapeutics-stock-insider-trading?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/top-executives-make-significant-moves-with-bicycle-therapeutics-stock-insider-trading?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","LENZ","BK4007","BK4139"],"gpt_icon":0},{"id":"2549569495","title":"Cathie Wood’s ARK Investment buys 659K shares of Beam Therapeutics today","url":"https://stock-news.laohu8.com/highlight/detail?id=2549569495","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549569495?lang=en_us&edition=fundamental","pubTime":"2025-07-08 08:10","pubTimestamp":1751933413,"startTime":"0","endTime":"0","summary":"20:08 EDT Cathie Wood’s ARK Investment buys 659K shares of Beam Therapeutics (BEAM) today Published first on TheFly – the ultimate source for real-...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cathie-woods-ark-investment-buys-659k-shares-of-beam-therapeutics-today-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cathie-woods-ark-investment-buys-659k-shares-of-beam-therapeutics-today-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4505","ARKK","BEAM","BK4007","BK4535","BK4544","BK4588","LENZ","BK4611","BK4585","BK4539","BK4139","BK4556"],"gpt_icon":0},{"id":"2549563488","title":"Century Therapeutics Stock Rises on Job Cuts","url":"https://stock-news.laohu8.com/highlight/detail?id=2549563488","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549563488?lang=en_us&edition=fundamental","pubTime":"2025-07-08 05:55","pubTimestamp":1751925300,"startTime":"0","endTime":"0","summary":"Shares of Century Therapeutics climbed after the company announced plans to cut 51% of its employees and focus on programs with the highest potential for value.The stock rose 11% to $0.61 in after-hours trading on Monday. Shares have declined 75% in the past 12 months through Monday's close.The company expects to incur charges of about $3.7 million for severance and other employee termination-related costs as a result of the cuts, according to a filing with the Securities and Exchange Commission on Monday.The reduction in force will amount to about 77 workers, given the company employed 150 full- and part-time employees as of March 1, according to its latest annual filing.The company expects the layoffs to be substantially complete by the end of the third quarter.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","IPSC","BK4505","CNBKA","BK4007","BK4139","BK4539"],"gpt_icon":0},{"id":"2549504555","title":"Century Therapeutics Announces Major Workforce Reduction","url":"https://stock-news.laohu8.com/highlight/detail?id=2549504555","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549504555?lang=en_us&edition=fundamental","pubTime":"2025-07-08 04:29","pubTimestamp":1751920161,"startTime":"0","endTime":"0","summary":"An announcement from Century Therapeutics ( ($IPSC) ) is now available. On July 1, 2025, Century Therapeutics‘ Board of Directors approved a signif...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/century-therapeutics-announces-major-workforce-reduction?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/century-therapeutics-announces-major-workforce-reduction?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","IPSC","CNBKA","BK4505","LENZ","BK4007","BK4139"],"gpt_icon":0},{"id":"2549927555","title":"Denali Therapeutics’ Promising Developments and FDA Milestones Support Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2549927555","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549927555?lang=en_us&edition=fundamental","pubTime":"2025-07-07 22:55","pubTimestamp":1751900115,"startTime":"0","endTime":"0","summary":"William Blair analyst Myles Minter has reiterated their bullish stance on DNLI stock, giving a Buy rating on June 23. Myles Minter has given his Bu...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/denali-therapeutics-promising-developments-and-fda-milestones-support-buy-rating-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/denali-therapeutics-promising-developments-and-fda-milestones-support-buy-rating-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ"],"gpt_icon":0},{"id":"2549558423","title":"William Blair Sticks to Their Buy Rating for LENZ Therapeutics (LENZ)","url":"https://stock-news.laohu8.com/highlight/detail?id=2549558423","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549558423?lang=en_us&edition=fundamental","pubTime":"2025-07-07 21:55","pubTimestamp":1751896545,"startTime":"0","endTime":"0","summary":"In a report released today, Lachlan Hanbury Brown from William Blair maintained a Buy rating on LENZ Therapeutics. The company’s shares opened toda...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/william-blair-sticks-to-their-buy-rating-for-lenz-therapeutics-lenz-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/william-blair-sticks-to-their-buy-rating-for-lenz-therapeutics-lenz-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ"],"gpt_icon":0},{"id":"2549530879","title":"Sector Update: Health Care Stocks Lean Lower Premarket Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=2549530879","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549530879?lang=en_us&edition=fundamental","pubTime":"2025-07-07 21:18","pubTimestamp":1751894286,"startTime":"0","endTime":"0","summary":"Health care stocks were leaning lower premarket Monday with the Health Care Select Sector SPDR Fund  declining by 0.1% and the iShares Biotechnology ETF  down 0.3% recently.KalVista Pharmaceuticals  shares were up more than 17% after the company said the US Food and Drug Administration approved its drug Ekterly, which is intended for treating acute attacks of hereditary angioedema in patients aged 12 and above.Jasper Therapeutics  shares were declining by more than 66% after the company said it is shutting down its asthma trial after discovering a faulty batch of its experimental drug was used to treat individuals who were enrolled in a trial evaluating briquilimab.Lenz Therapeutics  shares were up nearly 0.1% after the company and Laboratoires Thea said they signed an exclusive licensing and commercialization agreement to market LNZ100, Lenz's investigational eye drop for presbyopia, in Canada.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IBB","BK4007","JSPR","KALV","BK4581","LENZ","XLV","BK4539","BK4588","BK4585","BK4139"],"gpt_icon":0},{"id":"2549532168","title":"Denali Therapeutics’ FDA Priority Review for New Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2549532168","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549532168?lang=en_us&edition=fundamental","pubTime":"2025-07-07 20:28","pubTimestamp":1751891321,"startTime":"0","endTime":"0","summary":"Denali Therapeutics ( ($DNLI) ) has shared an announcement. On July 7, 2025, Denali Therapeutics announced that the FDA has accepted and granted Pr...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/denali-therapeutics-fda-priority-review-for-new-therapy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/denali-therapeutics-fda-priority-review-for-new-therapy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LENZ","BK4539","BK4007"],"gpt_icon":0},{"id":"2549532140","title":"Alterity Therapeutics Announces Change in Substantial Holding","url":"https://stock-news.laohu8.com/highlight/detail?id=2549532140","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549532140?lang=en_us&edition=fundamental","pubTime":"2025-07-07 20:27","pubTimestamp":1751891237,"startTime":"0","endTime":"0","summary":"An update from Alterity Therapeutics ( ($ATHE) ) is now available. On July 7, 2025, Alterity Therapeutics Limited announced a change in substantial...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/alterity-therapeutics-announces-change-in-substantial-holding-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/alterity-therapeutics-announces-change-in-substantial-holding-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4539","BK4007","BK4139"],"gpt_icon":0},{"id":"2549534011","title":"Lenz Therapeutics, Laboratoires Thea enter license, commercialization agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2549534011","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549534011?lang=en_us&edition=fundamental","pubTime":"2025-07-07 20:16","pubTimestamp":1751890588,"startTime":"0","endTime":"0","summary":"LENZ Therapeutics (LENZ) announced an exclusive license and commercialization agreement for Thea to register and commercialize LNZ100 for the treat...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lenz-therapeutics-laboratoires-thea-enter-license-commercialization-agreement-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lenz-therapeutics-laboratoires-thea-enter-license-commercialization-agreement-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4007","BK4539","LENZ"],"gpt_icon":0},{"id":"2549534393","title":"LENZ Therapeutics and Théa Ink $70M Deal for LNZ100 Eye Drop Commercialization in Canada","url":"https://stock-news.laohu8.com/highlight/detail?id=2549534393","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549534393?lang=en_us&edition=fundamental","pubTime":"2025-07-07 20:00","pubTimestamp":1751889648,"startTime":"0","endTime":"0","summary":"LENZ Therapeutics, Inc. has entered into an exclusive license and commercialization agreement with Laboratoires Théa for the Canadian market, focusing on the eye drop treatment LNZ100 for presbyopia. The agreement secures over $70 million in upfront and milestone payments for LENZ, along with double-digit royalties on net sales. Théa, a prominent company in eye-care product commercialization, will handle the development, manufacturing, registration, and marketing of LNZ100 in Canada. This partnership marks LENZ's third international commercialization deal for LNZ100, underscoring its commitment to broadening patient access to this innovative therapy globally. Jean-Frédéric Chibret, President of Théa, highlighted the potential of this promising treatment to address a widespread condition affecting millions of adults in Canada.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely informa","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250707:nNDL1vDXdw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LU2210149790.SGD","LENZ","IE00BKPKM429.USD","LU2095319765.USD","BK4112","IE00BGHQF748.EUR","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","BK4585","LU2210150020.SGD","BK4539","BK4139","BK4588","NDAQ"],"gpt_icon":0},{"id":"2549953438","title":"Lenz Therapeutics Inc - Eligible for Over $70 Mln in Payments and Royalties","url":"https://stock-news.laohu8.com/highlight/detail?id=2549953438","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549953438?lang=en_us&edition=fundamental","pubTime":"2025-07-07 20:00","pubTimestamp":1751889602,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250707:nTUA3H4NS0:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BK4539","LENZ","BK4139"],"gpt_icon":0},{"id":"2549352534","title":"Lenz Therapeutics and Laboratoires THÉa Announce Exclusive License and Commercialization Agreement for Lnz100 in Canada","url":"https://stock-news.laohu8.com/highlight/detail?id=2549352534","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549352534?lang=en_us&edition=fundamental","pubTime":"2025-07-07 20:00","pubTimestamp":1751889602,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250707:nTUA3H4NS0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LENZ","BK4539","BK4139","BK4007"],"gpt_icon":0},{"id":"2549534620","title":"Denali Therapeutics Announces FDA Acceptance and Priority Review of Biologics License Application (BLA) for Tividenofusp Alfa for Hunter Syndrome (MPS II)","url":"https://stock-news.laohu8.com/highlight/detail?id=2549534620","media":"GlobeNewswire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549534620?lang=en_us&edition=fundamental","pubTime":"2025-07-07 20:00","pubTimestamp":1751889600,"startTime":"0","endTime":"0","summary":"FDA assigns PDUFA target action date of January 5, 2026, for decision on accelerated approvalTividenofusp alfa is designed to deliver missing enzyme to entire body and cross blood-brain barrier into t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/07/07/3110980/0/en/Denali-Therapeutics-Announces-FDA-Acceptance-and-Priority-Review-of-Biologics-License-Application-BLA-for-Tividenofusp-Alfa-for-Hunter-Syndrome-MPS-II.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4135","LENZ","BK4539","CNS","BK4139","BK4007","BK4100","TV"],"gpt_icon":0},{"id":"2549346565","title":"Allarity Therapeutics Announces Appointment of Jeff Ervin as Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2549346565","media":"GlobeNewswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549346565?lang=en_us&edition=fundamental","pubTime":"2025-07-07 20:00","pubTimestamp":1751889600,"startTime":"0","endTime":"0","summary":"TARPON SPRINGS, Fla., July 7, 2025 -- Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib—a dif","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/07/07/3110957/0/en/Allarity-Therapeutics-Announces-Appointment-of-Jeff-Ervin-as-Chief-Financial-Officer.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PSQ","USJW.SI","QLD","CFO","MNQmain","NQmain","NVIW.SI","USAW.SI","LENZ","ALLR","ADHD","TQQQ","BK4539","QID","BK4139","SQQQ","BK4007",".IXIC","TSYW.SI"],"gpt_icon":1},{"id":"2549253463","title":"LENZ Therapeutics and Laboratoires Théa Announce Exclusive License and Commercialization Agreement for LNZ100 in Canada","url":"https://stock-news.laohu8.com/highlight/detail?id=2549253463","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549253463?lang=en_us&edition=fundamental","pubTime":"2025-07-07 20:00","pubTimestamp":1751889600,"startTime":"0","endTime":"0","summary":"Exclusive agreement includes over $70 million in upfront and milestone payments to LENZ in addition to double-digit royalties on net salesSAN DIEGO and CLERMONT-FERRAND, France, July  07, 2025  (GLOBE","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/07/07/3110985/0/en/LENZ-Therapeutics-and-Laboratoires-Th%C3%A9a-Announce-Exclusive-License-and-Commercialization-Agreement-for-LNZ100-in-Canada.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","LENZ","BK4139","BK4007"],"gpt_icon":0},{"id":"2549539217","title":"Unicycive Therapeutics to Present at the H.C. Wainwright 4th Annual Kidney Virtual Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2549539217","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549539217?lang=en_us&edition=fundamental","pubTime":"2025-07-07 19:00","pubTimestamp":1751886000,"startTime":"0","endTime":"0","summary":"LOS ALTOS, Calif., July  07, 2025  (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (“Unicycive” or the “Company”) (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patie","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/07/07/3110898/0/en/Unicycive-Therapeutics-to-Present-at-the-H-C-Wainwright-4th-Annual-Kidney-Virtual-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UNCY","BK4139","IE0009354923.USD","BK4539","BK4183","LENZ","BK4007","ODD"],"gpt_icon":0},{"id":"2549535187","title":"Truist Lowers Price Target on Edgewise Therapeutics to $46 From $50, Keeps Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2549535187","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549535187?lang=en_us&edition=fundamental","pubTime":"2025-07-07 18:29","pubTimestamp":1751884146,"startTime":"0","endTime":"0","summary":"Edgewise Therapeutics (EWTX) has an average rating of buy and mean price target of $38.45, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from maj","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["EWTX","LENZ"],"gpt_icon":0},{"id":"2549535803","title":"HighTide Therapeutics Completes Successful Share Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2549535803","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549535803?lang=en_us&edition=fundamental","pubTime":"2025-07-07 18:11","pubTimestamp":1751883106,"startTime":"0","endTime":"0","summary":"Hightide Therapeutics Inc ( ($HK:2511) ) has provided an announcement. HighTide Therapeutics, Inc. has successfully completed the placing of 56,555...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/hightide-therapeutics-completes-successful-share-placement?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/hightide-therapeutics-completes-successful-share-placement?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4539","LENZ","BK4007"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":10,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LENZ\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-05-08","symbol":"LENZ","fiscalQuarterEnding":"2024/03","expectedEps":-0.84,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715140800000,"reportTimeType":"pre","actualEps":-3.53},{"market":"US","date":"2024-03-22","symbol":"LENZ","defaultRemindTime":1711114200000,"type":"split","dateTimestamp":1711080000000,"forFactor":7,"toFactor":1,"ratio":7},{"date":"2024-03-22","symbol":"LENZ","amount":1.03,"announcedDate":null,"type":"dividend","market":"US","newRecordDate":"2024-03-18","name":"Therapeutics","recordDate":"2024-03-21","payableDate":"2024-03-18","currency":"USD","dateTimestamp":1711080000000,"payDate":"2024-03-21"},{"market":"US","date":"2021-08-12","symbol":"LENZ","fiscalQuarterEnding":"2021/06","expectedEps":-1.11,"name":null,"time":"","type":"earning","dateTimestamp":1628740800000,"reportTimeType":"","actualEps":-3.45}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LENZ\",market:\"US\",,,undefined,":[{"executeDate":"2024-03-22","recordDate":"2024-03-18","paymentDate":"2024-03-21","value":1.03,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LENZ\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":8,"updateTime":1742270400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/LENZ\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"LENZ","date":"2025-07-18","current":-20.381494,"percent":0.009677,"low":-20.747029,"twenty":-15.833323,"median":-10.791578,"eighty":-7.484747,"high":-5.069183,"avg":-11.412713,"sd":4.103005,"marketCap":973012543},"quantilePoints":[{"date":"2024-03-28","current":-7.959158,"twenty":-7.219077,"median":-6.108955,"eighty":-6.016992,"marketCap":556886354},{"date":"2024-04-05","current":-7.492045,"twenty":-7.873034,"median":-7.667213,"eighty":-6.662191,"marketCap":524203432},{"date":"2024-04-12","current":-7.929963,"twenty":-7.855517,"median":-7.667213,"eighty":-7.432197,"marketCap":554843672},{"date":"2024-04-19","current":-6.382653,"twenty":-7.855517,"median":-7.488396,"eighty":-6.783348,"marketCap":446581492},{"date":"2024-04-26","current":-5.638193,"twenty":-7.716113,"median":-7.451903,"eighty":-5.889996,"marketCap":394493084},{"date":"2024-05-03","current":-5.988527,"twenty":-7.671592,"median":-6.864363,"eighty":-5.803142,"marketCap":419005276},{"date":"2024-05-10","current":-5.317808,"twenty":-7.667213,"median":-6.108955,"eighty":-5.803142,"marketCap":393230653},{"date":"2024-05-17","current":-5.708011,"twenty":-7.597146,"median":-6.0013,"eighty":-5.749862,"marketCap":422084590},{"date":"2024-05-24","current":-5.428308,"twenty":-7.489126,"median":-6.006774,"eighty":-5.719496,"marketCap":401401679},{"date":"2024-05-31","current":-5.355793,"twenty":-7.479638,"median":-5.988527,"eighty":-5.522773,"marketCap":396039443},{"date":"2024-06-07","current":-5.193496,"twenty":-7.457742,"median":-5.904593,"eighty":-5.428999,"marketCap":384038248},{"date":"2024-06-14","current":-6.433167,"twenty":-7.451903,"median":-5.930138,"eighty":-5.428308,"marketCap":475706952},{"date":"2024-06-21","current":-6.236339,"twenty":-7.425628,"median":-5.992177,"eighty":-5.43107,"marketCap":461152311},{"date":"2024-06-28","current":-6.150011,"twenty":-7.389135,"median":-6.0013,"eighty":-5.439358,"marketCap":454768696},{"date":"2024-07-05","current":-6.098214,"twenty":-7.269437,"median":-6.014073,"eighty":-5.469746,"marketCap":450938528},{"date":"2024-07-12","current":-6.771573,"twenty":-6.771573,"median":-6.098214,"eighty":-5.493918,"marketCap":500730721},{"date":"2024-07-15","current":-7.261916,"twenty":-7.163847,"median":-6.103393,"eighty":-5.509112,"marketCap":536989651},{"date":"2024-08-02","current":-8.498134,"twenty":-7.266429,"median":-6.108573,"eighty":-5.524305,"marketCap":628403011},{"date":"2024-08-09","current":-8.328931,"twenty":-7.474529,"median":-6.146558,"eighty":-5.597209,"marketCap":615891126},{"date":"2024-08-16","current":-8.944708,"twenty":-7.671592,"median":-6.236339,"eighty":-5.641258,"marketCap":621424629},{"date":"2024-08-23","current":-8.79431,"twenty":-7.94748,"median":-6.352018,"eighty":-5.670717,"marketCap":610975896},{"date":"2024-08-30","current":-8.746816,"twenty":-8.006409,"median":-6.382653,"eighty":-5.719496,"marketCap":607676296},{"date":"2024-09-06","current":-9.451311,"twenty":-8.199004,"median":-6.419354,"eighty":-5.743293,"marketCap":656620360},{"date":"2024-09-13","current":-8.17293,"twenty":-8.352945,"median":-6.434893,"eighty":-5.773217,"marketCap":567806132},{"date":"2024-09-20","current":-8.7389,"twenty":-8.507104,"median":-6.459289,"eighty":-5.788545,"marketCap":607126363},{"date":"2024-09-27","current":-8.806184,"twenty":-8.638371,"median":-6.616182,"eighty":-5.792924,"marketCap":611800796},{"date":"2024-10-04","current":-8.897214,"twenty":-8.745233,"median":-7.269437,"eighty":-5.800953,"marketCap":618125029},{"date":"2024-10-11","current":-9.340491,"twenty":-8.850511,"median":-7.455552,"eighty":-5.81701,"marketCap":648921294},{"date":"2024-10-18","current":-10.417023,"twenty":-8.905129,"median":-7.492045,"eighty":-5.857882,"marketCap":723712222},{"date":"2024-10-25","current":-9.902504,"twenty":-9.0017,"median":-7.670862,"eighty":-5.904593,"marketCap":687966558},{"date":"2024-10-31","current":-10.939457,"twenty":-9.257377,"median":-7.718702,"eighty":-5.904593,"marketCap":760007820},{"date":"2024-11-08","current":-14.709443,"twenty":-9.419648,"median":-7.959158,"eighty":-5.955683,"marketCap":894466512},{"date":"2024-11-15","current":-15.344855,"twenty":-9.514636,"median":-8.00261,"eighty":-5.970448,"marketCap":933105265},{"date":"2024-11-22","current":-15.521232,"twenty":-9.76398,"median":-8.132103,"eighty":-5.988527,"marketCap":943830613},{"date":"2024-11-29","current":-16.100113,"twenty":-9.924668,"median":-8.17293,"eighty":-5.994366,"marketCap":979031755},{"date":"2024-12-06","current":-16.33076,"twenty":-10.388526,"median":-8.285117,"eighty":-6.004584,"marketCap":993057210},{"date":"2024-12-13","current":-13.920266,"twenty":-10.815972,"median":-8.351032,"eighty":-6.018452,"marketCap":846477455},{"date":"2024-12-20","current":-13.694141,"twenty":-11.182468,"median":-8.50374,"eighty":-6.082845,"marketCap":832727009},{"date":"2024-12-27","current":-14.476534,"twenty":-12.093039,"median":-8.531114,"eighty":-6.098214,"marketCap":880303552},{"date":"2025-01-03","current":-12.794163,"twenty":-13.449021,"median":-8.618187,"eighty":-6.102358,"marketCap":778000234},{"date":"2025-01-10","current":-11.912274,"twenty":-13.190334,"median":-8.707238,"eighty":-6.108649,"marketCap":724373495},{"date":"2025-01-17","current":-10.130408,"twenty":-13.019383,"median":-8.746816,"eighty":-6.115785,"marketCap":616019980},{"date":"2025-01-24","current":-11.197719,"twenty":-12.871045,"median":-8.79431,"eighty":-6.143105,"marketCap":680922085},{"date":"2025-01-31","current":-11.523339,"twenty":-12.794163,"median":-8.877425,"eighty":-6.150011,"marketCap":700722728},{"date":"2025-02-07","current":-12.070562,"twenty":-12.328345,"median":-8.905129,"eighty":-6.232886,"marketCap":733998807},{"date":"2025-02-14","current":-11.432889,"twenty":-12.292165,"median":-8.964497,"eighty":-6.236339,"marketCap":695222549},{"date":"2025-02-21","current":-11.279124,"twenty":-12.151063,"median":-8.998138,"eighty":-6.308164,"marketCap":685872246},{"date":"2025-02-28","current":-9.62841,"twenty":-12.079607,"median":-9.059485,"eighty":-6.342695,"marketCap":585493990},{"date":"2025-03-07","current":-10.297741,"twenty":-11.943932,"median":-9.320702,"eighty":-6.355126,"marketCap":626195310},{"date":"2025-03-14","current":-11.193196,"twenty":-11.879712,"median":-9.419648,"eighty":-6.365485,"marketCap":680647077},{"date":"2025-03-21","current":-14.554795,"twenty":-11.943932,"median":-9.482973,"eighty":-6.379634,"marketCap":724377586},{"date":"2025-03-28","current":-14.68208,"twenty":-12.421509,"median":-9.574004,"eighty":-6.398202,"marketCap":730712447},{"date":"2025-04-04","current":-12.728528,"twenty":-13.089934,"median":-9.668992,"eighty":-6.415901,"marketCap":633486102},{"date":"2025-04-11","current":-10.2603,"twenty":-12.90813,"median":-9.741473,"eighty":-6.42488,"marketCap":510644883},{"date":"2025-04-17","current":-12.761733,"twenty":-12.945214,"median":-9.779811,"eighty":-6.430405,"marketCap":635138674},{"date":"2025-04-25","current":-15.833323,"twenty":-13.271407,"median":-9.84549,"eighty":-6.435239,"marketCap":788008663},{"date":"2025-05-02","current":-15.982746,"twenty":-13.932929,"median":-9.940463,"eighty":-6.440764,"marketCap":795445305},{"date":"2025-05-09","current":-15.25222,"twenty":-14.136351,"median":-10.102399,"eighty":-6.452984,"marketCap":728141003},{"date":"2025-05-16","current":-16.118891,"twenty":-14.245886,"median":-10.138549,"eighty":-6.460191,"marketCap":769515850},{"date":"2025-05-23","current":-16.637714,"twenty":-14.356129,"median":-10.19625,"eighty":-6.460792,"marketCap":794284465},{"date":"2025-05-30","current":-17.410053,"twenty":-14.523491,"median":-10.236057,"eighty":-6.585104,"marketCap":831155927},{"date":"2025-06-06","current":-17.864023,"twenty":-14.65894,"median":-10.342966,"eighty":-6.96771,"marketCap":852828466},{"date":"2025-06-13","current":-17.439532,"twenty":-14.747436,"median":-10.384797,"eighty":-7.264924,"marketCap":832563235},{"date":"2025-06-20","current":-17.704839,"twenty":-14.88454,"median":-10.454615,"eighty":-7.299361,"marketCap":845229004},{"date":"2025-06-27","current":-17.752005,"twenty":-15.005667,"median":-10.623361,"eighty":-7.425628,"marketCap":847480696},{"date":"2025-07-03","current":-19.178768,"twenty":-15.33581,"median":-10.694071,"eighty":-7.451903,"marketCap":915594389},{"date":"2025-07-11","current":-20.198727,"twenty":-15.529319,"median":-10.766979,"eighty":-7.459202,"marketCap":964287236},{"date":"2025-07-18","current":-20.381494,"twenty":-15.833323,"median":-10.791578,"eighty":-7.484747,"marketCap":973012543}],"updateTime":1753108570486}}}